CRISPR Therapeutics (CRSP) PT Lowered to $98 at Jefferies
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $60.08 +8.02%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Jefferies analyst Maury Raycroft lowered the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $98.00 (from $100.00) while maintaining a Buy rating.
You May Also Be Interested In
- HSBC Downgrades HK Electric (2638:HK) (HKCVF) to Hold
- Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold
- Truist Securities Downgrades Procept BioRobotics Corp (PRCT) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
